Form D · Other Technology

DiCE MOLECULES HOLDINGS, LLC

South San Francisco, CA · CIK 0001645569

Offering snapshot reported Sep 7, 2021 · SEC filing

Reported sold
$60M
Offering amount: $60M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 7, 2021Initial$60,000,416No comparisonNot reportedSEC filing
Jan 22, 2021Initial$54,347,528No comparison27SEC filing
Jul 25, 2018Initial$40,481,981No comparison19SEC filing
Jun 18, 2015Initial$3,999,990No comparison11SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-412563

Source: Form D, filed Sep 7, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Bedbrook Director
Shaan Gandhi Director
Pehr Harbury Director
Kevin Judice Director, Executive
Phillip Patten Director
Michael Rabson Executive, Promoter
Scott Robertson Executive
Michael Rubin Director
Richard Scheller Director
Jim Scopa Director
Jake Simson Director
Sharon Tetlow Director
Stephen Zachary Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
279 E. Grand Avenue Suite 300, Lobby B
South San Francisco, CA, 94080